Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
- 26 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Internal and Emergency Medicine
- Vol. 16 (3), 799-800
- https://doi.org/10.1007/s11739-021-02677-0
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactionsInternal and Emergency Medicine, 2021
- Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—commentInternal and Emergency Medicine, 2021
- Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)Frontiers in Pharmacology, 2020